Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 17/20 | 0.61 |
| ▸ | TLR7 | Q9NYK1 | 8/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18923200 | 0.87 | TLR8 (0.72) | TLR8TLR7KCNH2 | |
| SCHEMBL18109522 | 0.83 | TLR8 (0.77) | TLR8TLR7KCNH2 | |
| SCHEMBL18109524 | 0.83 | TLR8 (0.77) | TLR8TLR7KCNH2 | |
| SCHEMBL24621642 | 0.81 | TLR8 (0.64) | TLR8TLR7KCNH2ADORA3ADORA2A | |
| SCHEMBL18109493 | 0.78 | TLR8 (0.87) | TLR8TLR7KCNH2 | |
| SCHEMBL18109496 | 0.78 | TLR8 (0.87) | TLR8TLR7KCNH2 | |
| SCHEMBL18109344 | 0.77 | TLR8 (0.45) | TLR8TLR7 | |
| SCHEMBL18109343 | 0.77 | TLR8 (0.45) | TLR8TLR7 | |
| SCHEMBL18109621 | 0.76 | TLR8 (0.70) | TLR8TLR7KCNH2ADORA1 | |
| SCHEMBL18109622 | 0.76 | TLR8 (0.70) | TLR8TLR7KCNH2ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670205-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-9670205-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | TLR8, TLR3, TLR6 | TLR8 1/4885TLR7 9/4885KCNH2 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.